Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Research graph
References from GULP1 Fuels Resistance to PD-1 Blockade through Lipid-Mediated Metabolic Reprogramming of Tumor-Associated Macrophages in Gastric Cancer. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1016/s0140-6736(20)31288-5
10.1016/s0140-6736(20)31288-5 · External reference
Global burden of gastric cancer: Epidemiological trends, risk factors, screening and prevention
10.1038/s41571-023-00747-0 · 2023 · External reference
10.1016/j.cell.2023.03.006
10.1016/j.cell.2023.03.006 · External reference
10.1056/nejmoa2201445
10.1056/nejmoa2201445 · External reference
10.1126/science.aar4060
10.1126/science.aar4060 · External reference
10.1158/2159-8290.cd-20-1312
10.1158/2159-8290.cd-20-1312 · External reference
Comprehensive molecular characterization of gastric adenocarcinoma
10.1038/nature13480 · 2014 · External reference
Current developments in gastric cancer: From molecular profiling to treatment strategy
10.1038/s41575-022-00703-w · 2023 · External reference
10.1200/jco.19.02105
10.1200/jco.19.02105 · External reference
10.1136/gutjnl-2022-329134
10.1136/gutjnl-2022-329134 · External reference
Roles of tumor-associated macrophages in anti-PD-1/PD-L1 immunotherapy for solid cancers
10.1186/s12943-023-01725-x · 2023 · External reference
TREM2 facilitates gastric cancer progression and immune evasion via inhibiting TRIM21-mediated STAT1 degradation in tumor-associated macrophages
10.1038/s41419-025-08198-4 · 2025 · External reference
Blockade of CLEVER-1 restrains immune evasion and enhances anti-PD-1 immunotherapy in gastric cancer
10.1136/jitc-2024-011080 · 2025 · External reference
10.1016/j.cell.2023.02.020
10.1016/j.cell.2023.02.020 · External reference
Macrophage-targeted immunocytokine leverages myeloid, T, and NK cell synergy for cancer immunotherapy
10.1016/j.cell.2025.10.030 · 2025 · External reference
10.1016/j.trecan.2019.10.007
10.1016/j.trecan.2019.10.007 · External reference
10.1158/0008-5472.can-19-2994
10.1158/0008-5472.can-19-2994 · External reference
GULP1 regulates the NRF2-KEAP1 signaling axis in urothelial carcinoma
10.1126/scisignal.aba0443 · 2020 · External reference
10.3350/cmh.2024.1038
10.3350/cmh.2024.1038 · External reference
The value of GULP1 in cancer prognosis and immunotherapy, validated from pan-cancer analysis to pancreatic cancer
10.1038/s41598-025-99909-6 · 2025 · External reference
A novel tumor microenvironment-related gene signature for prognostic prediction of intrahepatic cholangiocarcinoma
10.1038/s41598-025-25463-w · 2025 · External reference
Japanese classification of gastric carcinoma: 3rd English edition
10.1007/s10120-011-0041-5 · 2011 · External reference
10.1016/j.jhep.2024.02.009
10.1016/j.jhep.2024.02.009 · External reference
Phospholysine phosphohistidine inorganic pyrophosphate phosphatase suppresses insulin-like growth factor 1 receptor expression to inhibit cell adhesion and proliferation in gastric cancer
10.1002/mco2.472 · 2024 · External reference
Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer
10.1038/s41591-018-0101-z · 2018 · External reference
Inference and analysis of cell-cell communication using CellChat
10.1038/s41467-021-21246-9 · 2021 · External reference
10.1016/j.ccell.2025.03.015
10.1016/j.ccell.2025.03.015 · External reference
Insig-2, a second endoplasmic reticulum protein that binds SCAP and blocks export of sterol regulatory element-binding proteins
10.1073/pnas.162488899 · 2002 · External reference
10.1038/s41586-020-2183-2
10.1038/s41586-020-2183-2 · External reference
HSPA8 dampens SCAP/INSIG split and SREBP activation by reducing PKR-mediated INSIG phosphorylation
10.1016/j.celrep.2025.115339 · 2025 · External reference
GULP1 deficiency reduces adipogenesis and glucose uptake via downregulation of PPAR signaling and disturbing of insulin/ERK signaling in 3T3-L1 cells
10.1002/jcp.31173 · 2024 · External reference
The cellular adaptor GULP1 interacts with ATG14 to potentiate autophagy and APP processing
10.1007/s00018-024-05351-8 · 2024 · External reference
10.1038/s41590-020-0769-3
10.1038/s41590-020-0769-3 · External reference
10.1038/s41586-024-08290-3
10.1038/s41586-024-08290-3 · External reference
CD36, a signaling receptor and fatty acid transporter that regulates immune cell metabolism and fate
10.1084/jem.20211314 · 2022 · External reference
10.1016/j.cmet.2021.02.015
10.1016/j.cmet.2021.02.015 · External reference
10.1016/j.immuni.2024.08.015
10.1016/j.immuni.2024.08.015 · External reference
10.1158/2159-8290.cd-24-1409
10.1158/2159-8290.cd-24-1409 · External reference
10.1016/j.cmet.2022.09.023
10.1016/j.cmet.2022.09.023 · External reference
10.1016/j.cmet.2013.05.017
10.1016/j.cmet.2013.05.017 · External reference
FABP5+ lipid-loaded macrophages process tumour-derived unsaturated fatty acid signal to suppress T-cell antitumour immunity
10.1016/j.jhep.2024.09.029 · 2025 · External reference
10.1038/s43018-025-00937-y
10.1038/s43018-025-00937-y · External reference
AMPKα1-mediated ZDHHC8 phosphorylation promotes the palmitoylation of SLC7A11 to facilitate ferroptosis resistance in glioblastoma
10.1016/j.canlet.2024.216619 · 2024 · External reference
Intracellular HMGB1 as a novel tumor suppressor of pancreatic cancer
10.1038/cr.2017.51 · 2017 · External reference
Extracellular HMGB1 blockade inhibits tumor growth through profoundly remodeling immune microenvironment and enhances checkpoint inhibitor-based immunotherapy
10.1136/jitc-2020-001966 · 2021 · External reference
Multifunctional glycyrrhizic acid-loaded nanoplatform combining ferroptosis induction and HMGB1 blockade for enhanced tumor immunotherapy
10.1186/s12951-025-03307-z · 2025 · External reference
10.1016/j.canlet.2018.06.030
10.1016/j.canlet.2018.06.030 · External reference
10.1016/j.ccell.2024.03.005
10.1016/j.ccell.2024.03.005 · External reference